Christina Wenglen

Christina Wenglen

Company: Anamar

Job title: Head of Research


Panel Discussion: What’s Missing? Uncovering the Questions that Need to Be Answered in the Next 12 Months of Research & Drug Development 2:30 pm

How much closer is the fibrosis field to more effective and disease modifying antifibrotics?Read more

day: Day Two

Understanding the Role of the 5-HT2B Receptor in Fibrosis with Special Focus on Systemic Sclerosis-ILD 5:00 pm

Exploring the mechanism of action Using a variety of preclinical models to evaluate the therapeutic’s effectiveness Harnessing RNA sequencing to show target engagement in relevant cells Moving from Phase 1 into systemic sclerosis patients with focus on biomarkersRead more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.